1. Home
  2. CVGW vs TRDA Comparison

CVGW vs TRDA Comparison

Compare CVGW & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calavo Growers Inc.

CVGW

Calavo Growers Inc.

N/A

Current Price

$25.16

Market Cap

466.0M

ML Signal

N/A

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$13.50

Market Cap

481.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVGW
TRDA
Founded
1924
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.0M
481.6M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
CVGW
TRDA
Price
$25.16
$13.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$33.50
$20.00
AVG Volume (30 Days)
170.2K
191.9K
Earning Date
04-30-2026
05-25-2026
Dividend Yield
3.16%
N/A
EPS Growth
1950.00
N/A
EPS
1.11
N/A
Revenue
$648,434,000.00
$25,421,000.00
Revenue This Year
$3.49
$39.97
Revenue Next Year
$11.23
$53.29
P/E Ratio
$22.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.40
$4.93
52 Week High
$28.72
$13.30

Technical Indicators

Market Signals
Indicator
CVGW
TRDA
Relative Strength Index (RSI) 40.89 64.65
Support Level $24.22 $9.59
Resistance Level $27.14 N/A
Average True Range (ATR) 0.58 0.83
MACD -0.25 0.14
Stochastic Oscillator 4.03 89.36

Price Performance

Historical Comparison
CVGW
TRDA

About CVGW Calavo Growers Inc.

Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: